Ozempic was supposed to be a gut story. Then Allison Shapiro looked at the brain scans. An assistant professor at the ...

Doctronic reports that Foundayo, an oral GLP-1 for diabetes, shows promise but lacks long-term safety data beyond 68 weeks; ...

The video outlines findings on how high-protein meals that naturally raise GLP-1 relate to lower cravings and steadier ...

This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent ...

A new study shows oral GLP-1 drugs suppress hedonic eating through a deep-brain reward circuit linked to dopamine release, potentially extending their use beyond weight loss.

If you've struggled mightily to lose weight and keep it off long term, bestselling author Mary Kay Andrews, 71, can ...

Glucagon-like peptide-1 (GLP-1) receptor agonists, or GLP-1 drugs, have quickly risen to popularity. They are already shaping food trends in major ways. But this could be only the beginning. The drugs ...

SAN DIEGO — New research is uncovering how medications targeting the glucagon-like peptide-1 (GLP-1) system affect brain circuits involved in nausea, thirst, and pleasurable behaviors. These findings ...

New research shows GLP-1 drugs like Ozempic may reduce sleep apnea severity — here's what the latest science says ...

GoodRx reports that Foundayo, a new oral weight-loss pill, is FDA-approved for obesity treatment, offering an alternative to ...